Medicamen Biotech Ltd
Board Meeting Outcome for Financial Results For The Quarter And Nine Months Period Ended On 31St Dec
03:41 PM, 10th Feb 2023
We wish to inform you that the Board of Directors of the Company at its meeting held today approved the Un-Audited Financial Results (Standalone and Consolidated) of the Company for the quarter and nine months ended on December 31 2022.Pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we enclose the following:a) Statement showing the Un-Audited Financial Results (Standalone & Consolidated) of the Company for the quarter and nine months ended on December 31 2022 as Annexure-A andb) Limited Review Report from Rai Qimat & Associates Chartered Accountants on the Un- Audited Financial Results (Standalone & Consolidated) as Annexure-Bc) An Investor Presentation of the company is enclosed as Annexure-CThe meeting of the Board of Directors commenced on 02.30 p.m. and concluded at 03.30 p.m.